September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Aspirin and Diabetic Retinopathy: the Singapore Epidemiology of Eye Disease (SEED) study
Author Affiliations & Notes
  • Yuan Shi
    Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
  • Yih-Chung Tham
    Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
  • Robyn Jennifer Tapp
    Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
  • GAVIN TAN
    Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
  • Paul Mitchell
    The University of Sydney, Sydney, New South Wales, Australia
  • Jie Jin Wang
    The University of Sydney, Sydney, New South Wales, Australia
  • Yin-Bun Cheung
    Duke-NUS Medical School, Singapore, Singapore
  • Ching-Yu Cheng
    Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
  • Tien Yin Wong
    Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
  • Footnotes
    Commercial Relationships   Yuan Shi, None; Yih-Chung Tham, None; Robyn Tapp, None; GAVIN TAN, None; Paul Mitchell, None; Jie Jin Wang, None; Yin-Bun Cheung, None; Ching-Yu Cheng, None; Tien Yin Wong, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 1595. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Yuan Shi, Yih-Chung Tham, Robyn Jennifer Tapp, GAVIN TAN, Paul Mitchell, Jie Jin Wang, Yin-Bun Cheung, Ching-Yu Cheng, Tien Yin Wong; Aspirin and Diabetic Retinopathy: the Singapore Epidemiology of Eye Disease (SEED) study. Invest. Ophthalmol. Vis. Sci. 2016;57(12):1595.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Purpose : To determine the cross-sectional association between aspirin use and DR among persons with diabetes in a population-based study.

Methods : Participants aged >40 years were recruited from the Singapore Epidemiology of Eye Diseases (SEED) Study. Diabetes was defined based on random glucose >= 11.1 mmol/L, use of diabetic medication, or a previous physician diagnosis. Retinal photographs were graded for DR according to the modified Airlie House classification. Vision threatening diabetic retinopathy (VTDR) was further defined as the presence of severe non-proliferative DR, proliferative DR, or clinically significant macular oedema. The association between aspirin use and the presence of any DR or VTDR was determined using multivariable logistic regressions, adjusted for age, gender, ethnicity, history of cardiovascular disease and other potential confounders.

Results : We included 2,075 participants with diabetes who had complete data about systemic conditions and DR. Of these, 400(19.3%) had history of cardiovascular diseases, 716 (34.5%) had any DR and 178 (8.6%) had VTDR. After adjusting for age, gender, ethnicity, socio-economic status, body mass index, HbA1c, hypertension, cholesterol levels, aspirin use was significantly associated with the likelihood of having any DR (OR = 1.41, 95% CI: 1.09 to 1.81, P = 0.008) and VTDR (odds ratio [OR] =1.90, 95% confidence interval [CI]: 1.29 to 2.82, P = 0.001). After further adjustment for the presence of cardio-vascular diseases, the associations between aspirin and VTDR (OR = 1.66, 95% CI: 1.07 to 2.54, P = 0.021) remained significant. In analyses stratified by cardiovascular disease, the relationship between aspirin and VTDR was similar among persons with (OR 1.67, 95% CI: 0.85 to 3.35, P = 0.139) and without (OR 1.48, 95% CI: 0.8 to 2.57, P = 0.187) cardiovascular disease.

Conclusions : Persons with diabetes who were on aspirin were more likely to have DR, particularly VTDR. Whether these findings suggested a possible complication of taking aspirin or whether it reflects increased severity of diabetes among patients on aspirin requires further clinical studies.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×